William Gray
MD, FSCAI
System Chief/President
Main Line Health/Lankenau Heart Institute

William A. Gray, M.D. FACC FSCAI
System Chief, Division of Cardiovascular Diseases of Main Line Health
President, Lankenau Heart Institute

William A. Gray, M.D., is an interventional cardiologist, board certified in internal medicine, interventional cardiology, vascular and endovascular medicine. Dr. Gray was at the Center for Interventional Vascular Therapy as Director, Endovascular Intervention at New York Columbia-Presbyterian Hospital.

Prior to joining Columbia University Dr. Gray was Director of the Endovascular Care at Swedish Medical Center from 1999-2005. Before Seattle, Dr. Gray practiced at Southwest Cardiology where he directed research, served as vice-chair of the Cardiology division at Presbyterian Hospital in Albuquerque, N.M., and was a founding member of the Heart Hospital of New Mexico.

Dr. Gray specializes in cardiac/structural and peripheral arterial disease diagnosis and treatment as well as non-surgical modalities for stroke prevention, research into preventing the reoccurrence of disease following successful angioplasty or stenting.

Dr. Gray has been principal investigator for numerous clinical trials, and is routinely asked to speak at national and international conferences. He has also been a consultant and device/procedure proctor for numerous medical corporations, and has been a journal reviewer for the American Medical Association.

Dr. Gray holds a bachelor’s degree in Chemistry from Dickinson College in Carlisle, PA and graduated from Temple University’s School of Medicine in Philadelphia. Dr. Gray’s postgraduate training included an internship, residency, and Chief Residency in Internal Medicine at Brown University/Rhode Island Hospital in Providence, R.I., where he also completed a clinical/research/ interventional fellowship in Cardiology.

Sessions

Register

Case Based Roundtable: Aorto-Iliac Disease

Sunday, February 02, 2025
9:35 AM - 10:00 AM

Controversy: Should patient with asymptomatic carotid disease be treated and with what intervention should be used? CEA, TFCAS or TCAR

Monday, February 03, 2025
8:30 AM - 8:40 AM

Panel Discussion & Audience Vote

Monday, February 03, 2025
8:40 AM - 8:45 AM

Panel Discussion & Audience Vote

Monday, February 03, 2025
8:55 AM - 9:00 AM

Panel Discussion & Audience Vote

Monday, February 03, 2025
9:10 AM - 9:15 AM

Panel Discussion & Audience Vote

Monday, February 03, 2025
9:25 AM - 9:30 AM

Panel Discussion & Audience Vote

Monday, February 03, 2025
9:54 AM - 10:00 AM

Live Cases: MCVI

Monday, February 03, 2025
10:00 AM - 11:00 AM

Are There Any Unanswered Questions Left in Carotid Disease Management?

Monday, February 03, 2025
12:03 PM - 12:11 PM

Panel Discussion

Monday, February 03, 2025
12:43 PM - 12:55 PM